Vivmark director sells 1,130 shares at $65
A VIVMARK RESIDENTIAL director disclosed a modest open-market share sale and continues to hold several thousand shares, including restricted stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VIVMARK RESIDENTIAL (VMRK) director Chris Carr reported selling 1,130 Common Shares Of Beneficial Interest on September 9, 2026 in an open-market or private transaction at $65.28 per share. After this sale, he directly holds 4,461 shares, including restricted shares scheduled to vest in the future, and no Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares Of Beneficial Interest F1 | 1,130 | $65.28 | $74K |
Footnotes (1)
- F1. Direct total includes restricted shares of Vivmark Residential scheduled to vest in the future.
Key Figures
Key Terms
open market or private transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VMRK director Chris Carr report?
Does the VMRK Form 4 indicate use of a Rule 10b5-1 trading plan?
What type of security did Chris Carr trade in VMRK?
Is Chris Carr's ownership in VMRK direct or indirect after the sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.